Lili Wei

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Journal of Hematology & Oncology · 2018 · 536 citations · Full text

Medicine, Hematology, Immunology +16

Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells

Qian Zhang, Ruixian Liu, Ka‐Wo Chan et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 165 citations · Full text

Medicine, Molecular Biology, Oncology +17

PROX1 Promotes Hepatocellular Carcinoma Metastasis By Way of Up-Regulating Hypoxia-Inducible Factor 1α Expression and Protein Stability

Yanfeng Liu, Jubo Zhang, Yi Qin et al. · Hepatology · 2013 · 114 citations · Full text

Medicine, Molecular Biology, Oncology +16

Management of cytokine release syndrome related to CAR-T cell therapy

Hongli Chen, Fangxia Wang, Pengyu Zhang et al. · Frontiers of Medicine · 2019 · 106 citations

Life Sciences, Immunology, Immunoregulation +13

miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer

Qiong Lou, Ruixian Liu, Xiangling Yang et al. · Journal for ImmunoTherapy of Cancer · 2019 · 102 citations · Full text

Medicine, Cancer Biology, Oncology +17